These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8537140)

  • 1. Assessment of the use of cefixime for switch therapy.
    Low DE
    Infection; 1995; 23 Suppl 2():S91-4. PubMed ID: 8537140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of the clinical features of cefixime.
    Adam D
    Chemotherapy; 1998 Sep; 44 Suppl 1():1-5. PubMed ID: 9797415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefixime for switch therapy.
    Hamilton-Miller J
    Chemotherapy; 1998 Sep; 44 Suppl 1():24-7. PubMed ID: 9797420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outpatient therapy with ceftriaxone and oral cefixime for selected febrile children with sickle cell disease.
    Williams LL; Wilimas JA; Harris SC; Day SW; Dancy RM; Wang WC
    J Pediatr Hematol Oncol; 1996 Aug; 18(3):257-61. PubMed ID: 8689337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral cephalosporins for use in a parenteral-to-oral switch programme.
    Rimmer DM
    Infection; 1995; 23 Suppl 2():S87-90. PubMed ID: 8537139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cefixime, the first oral third-generation cephalosporin].
    Roche G
    Presse Med; 1989 Oct; 18(32):1541-4. PubMed ID: 2530527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of cefixime versus amoxicillin-clavulanate following ceftriaxone therapy of pneumonia.
    Amir J; Harel L; Eidlitz-Markus T; Varsano I
    Clin Pediatr (Phila); 1996 Dec; 35(12):629-33. PubMed ID: 8970755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral versus initial intravenous therapy for urinary tract infections in young febrile children.
    Hoberman A; Wald ER; Hickey RW; Baskin M; Charron M; Majd M; Kearney DH; Reynolds EA; Ruley J; Janosky JE
    Pediatrics; 1999 Jul; 104(1 Pt 1):79-86. PubMed ID: 10390264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of FCE 22891 compared with cefuroxime axetil and cefixime in pulmonary and subcutaneous infections in mice.
    Rossi R; Castellani P; Younes G; Della Bruna C
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():149-55. PubMed ID: 2732136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of cefprozil, cefpodoxime proxetil, loracarbef, cefixime, and ceftibuten.
    Schatz BS; Karavokiros KT; Taeubel MA; Itokazu GS
    Ann Pharmacother; 1996 Mar; 30(3):258-68. PubMed ID: 8833562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of 5-day and 10-day cefixime in the treatment of acute exacerbation of chronic bronchitis.
    Lorenz J
    Chemotherapy; 1998 Sep; 44 Suppl 1():15-8. PubMed ID: 9797418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Once-a-day therapy for sinusitis: a comparison study of cefixime and amoxicillin.
    Edelstein DR; Avner SE; Chow JM; Duerksen RL; Johnson J; Ronis M; Rybak LP; Bierman WC; Matthews BL; Kohlbrenner VM
    Laryngoscope; 1993 Jan; 103(1 Pt 1):33-41. PubMed ID: 8421417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative study of intravenous ceftriaxone followed by oral cefixime versus ceftriaxone alone in the treatment of severe upper urinary tract infections].
    Regnier B
    Presse Med; 1989 Oct; 18(32):1617-21. PubMed ID: 2530546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination cefixime/amoxicillin against penicillin-resistant Streptococcus pneumoniae infection.
    Matsumoto Y
    Chemotherapy; 1998 Sep; 44 Suppl 1():6-9. PubMed ID: 9797416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Switch therapy in community-acquired pneumonia.
    Nathwani D; Boyter A; Fegan PG; Davey P
    Arch Intern Med; 1996 Jun; 156(11):1235. PubMed ID: 8639018
    [No Abstract]   [Full Text] [Related]  

  • 16. Cefixime.
    Leggett NJ; Caravaggio C; Rybak MJ
    DICP; 1990 May; 24(5):489-95. PubMed ID: 2188437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of oral cefixime and intravenous ceftriaxone followed by oral amoxicillin in disseminated Lyme borreliosis.
    Oksi J; Nikoskelainen J; Viljanen MK
    Eur J Clin Microbiol Infect Dis; 1998 Oct; 17(10):715-9. PubMed ID: 9865985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [5-day therapy of bacterial pharyngitis and tonsillitis with cefixime. Comparison with 10 day treatment with penicillin V. Cefixime Study Group].
    Adam D; Hostalek U; Tröster K
    Klin Padiatr; 1996; 208(5):310-3. PubMed ID: 8992100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical role of cefixime in community-acquired infections.
    Chemotherapy; 1998 Sep; 44 Suppl 1():35-8. PubMed ID: 9797423
    [No Abstract]   [Full Text] [Related]  

  • 20. Cefixime. A review of its antibacterial activity. Pharmacokinetic properties and therapeutic potential.
    Brogden RN; Campoli-Richards DM
    Drugs; 1989 Oct; 38(4):524-50. PubMed ID: 2684593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.